Summary: Unlearning a fear response—a process called fear extinction—is essential for recovering from traumatic or threatening experiences. A recent study identifies a specific biological “on/off switch” in the brain that can accelerate this process, revealing a potential target for improving treatments for anxiety disorders and PTSD.
Researchers found that activating a defined population of neurons that produce corticotropin-releasing factor (CRF) in the bed nucleus of the stria terminalis (BNST) enables faster unlearning of fear. This discovery clarifies a neural mechanism of emotional flexibility and points toward new strategies that might enhance exposure-based therapies or pharmacological interventions for fear-related conditions.
Key findings
- CRF “switch” in the BNST: Activating CRF-expressing neurons in the BNST acts like a core switch that accelerates fear extinction.
- Serotonin receptor involvement: The effect depends on serotonergic signaling via the 5-HT2C receptor. When this receptor is removed or its influence reduced, CRF neurons support extinction more effectively.
- Precise chemogenetic control: Scientists used chemogenetics to selectively activate or inhibit BNST CRF neurons, demonstrating a causal role for these cells in regulating the rate of fear unlearning.
- Relevance to treatments: The BNST–CRF circuit helps explain why long-term SSRI treatment can eventually reduce anxiety: chronic modulation of serotonin receptors may reshape this circuit to improve emotional flexibility.
- Implications for PTSD and anxiety: Targeting the BNST–CRF pathway could supplement existing therapies by speeding up the formation of new safety memories.
Source: RUB (Ruhr University Bochum)
Why fear extinction matters
Fear extinction is an active learning process: the brain must form a new memory that a previously dangerous cue is now safe. This is not simple forgetting but the creation of an alternative safety memory that suppresses the original fear association. Efficient extinction is central to therapeutic approaches for anxiety disorders and post-traumatic stress disorder (PTSD).
A research team led by Dr. Katharina Spoida at Ruhr University Bochum demonstrated that selective activation of BNST CRF neurons causes mice to extinguish learned fear responses significantly faster. Their results were published in Translational Psychiatry on January 10, 2026.
How the mechanism was revealed
Earlier work from the same group showed that mice lacking the 5-HT2C serotonin receptor extinguish fear more rapidly. The current study builds on that observation and identifies the cellular mechanism responsible: CRF-producing neurons within the BNST act as a pivotal node controlling extinction speed.
By manipulating this neuronal population, researchers could reproduce the accelerated extinction seen in receptor-deficient mice—this time in genetically normal, or wild-type, animals. That provides the first direct demonstration of a specific brain circuit that can be targeted to speed up fear unlearning.
Chemogenetics: a precise on/off switch
The team used chemogenetic tools (DREADDs) to control BNST CRF neurons with high specificity. Chemogenetics functions like a molecular on/off switch: activating the engineered receptors engages the target neurons, while inhibiting them silences activity. This approach allowed the team to observe how altering BNST CRF activity changes fear behavior.
When BNST CRF neurons were inhibited in 5-HT2C receptor knockout mice, extinction slowed down. Conversely, activating the same neurons in wild-type mice sped up extinction. These bidirectional manipulations confirm that BNST CRF neurons can both promote and impede the formation of safety memories depending on their activity state.
Serotonin, SSRIs, and clinical implications
The absence of the 5-HT2C receptor shifts serotonergic regulation in the BNST so that CRF neurons more strongly support extinction. That offers a mechanistic link to why selective serotonin reuptake inhibitors (SSRIs), which change serotonin signaling over time, can reduce anxiety with prolonged treatment despite sometimes increasing anxiety acutely.
These findings suggest the therapeutic effects of chronic SSRIs might be mediated, in part, by gradual remodeling of the BNST–CRF circuit. Understanding this pathway opens possibilities for targeted pharmacological or neuromodulatory strategies that enhance fear extinction and improve outcomes for patients with PTSD or anxiety disorders.
Funding: German Research Foundation (project numbers 316803389 and 492434978).
Frequently asked questions
A: Because the brain must actively form a new memory that signals safety; this process, called fear extinction, requires neural changes rather than passive forgetting. The BNST–CRF circuit helps determine how quickly that new safety memory forms.
A: It is an important step. Identifying the BNST CRF neurons as a key circuit gives researchers a concrete target for drugs or stimulation methods that might speed up extinction, but translation to human treatments will require further research and clinical trials.
A: SSRIs alter serotonin signaling over weeks to months, which can modify receptors like 5-HT2C and thereby influence the BNST–CRF pathway. This gradual change may underlie the delayed therapeutic benefit of SSRIs for anxiety.
About this research
Author: Katharina Spoida
Source: RUB, Ruhr University Bochum
Contact: Katharina Spoida – RUB
Image credit: Neuroscience News
Original research: Chemogenetic modulation of CRF neurons in the BNST compensates for phenotypic behavioral differences in fear extinction learning of 5-HT2C receptor mutant mice. DOI: 10.1038/s41398-025-03799-1
Abstract (summary)
Psychopharmacotherapy for anxiety and stress-related disorders often involves medications that alter serotonin balance, such as SSRIs. Acute SSRI treatment can initially increase anxiety, an effect linked to 5-HT2C receptors in the BNST. While many studies implicate 5-HT2C receptors in anxiety, their role in learned fear and extinction has been less clear. Global loss of 5-HT2C receptors enhances fear extinction in mice without affecting fear acquisition. Using chemogenetic activation and inactivation of BNST CRF neurons, the current study demonstrates that modulating this neuronal population bidirectionally controls extinction. Activating BNST CRF neurons promotes extinction in wild-type mice, while inhibiting them impairs extinction in 5-HT2C receptor knockout mice. These results point to a BNST–CRF mechanism that may underlie extinction-enhancing effects and have relevance for developing treatments for PTSD and anxiety disorders.